Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that as foreshadowed at the recent Annual General Meeting the Board ...
The landmark deal to develop Eatonville’s historic Hungerford property tops our 2025 stories of the year in real estate.
Up-and-coming managers role play as CEOs in an in-house strategy game that tests their mettle for decision-making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback